Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

Autor: N'Goran, Eliézer K *, Odiere, Maurice R *, Assandé Aka, Ronald, Ouattara, Mamadou, Aka, N A David, Ogutu, Bernhards, Rawago, Fredrick, Bagchus, Wilhelmina M, Bödding, Matthias, Kourany-Lefoll, Elly, Tappert, Aliona, Yin, Xiaoyan, Bezuidenhout, Deon, Badenhorst, Henk, Huber, Eric, Dälken, Benjamin *, Haj-Ali Saflo, Okba
Zdroj: In The Lancet Infectious Diseases July 2023 23(7):867-876
Databáze: ScienceDirect